Legislation

This resolution extends the contract with Heluna Health for the San Francisco Homeless Outreach Team by 19 months and increases the total funding by $12,685,125, bringing the total contract amount to $51,819,067. It aims to continue providing outreach and case management services for people experiencing homelessness in the city.

Resolution approving the seventh amendment to the contract between the City and County of San Francisco and Heluna Health to provide comprehensive outreach and case management programming to meet the needs of people experiencing homelessness in San Francisco, known as the San Francisco Homeless Outreach Team, to extend the contract agreement term for 19 months from November 30, 2021, for a total term of August 1, 2014, through June 30, 2023, and increasing the contract amount by $12,685,125 for a total contract amount not to exceed $51,819,067.

This resolution allows the Department of Public Health to use a $6 million grant for a mental health program aimed at supporting student services from October 1, 2021, to September 30, 2025. It has been officially approved and is now in effect.

Resolution retroactively authorizing the Department of Public Health to accept and expend a grant in the amount of $6,000,000 from the Mental Health Services Oversight and Accountability Commission for participation in a program, entitled “Mental Health Student Services Act of 2019,” for the period of October 1, 2021, through September 30, 2025.

This hearing addresses issues with Shared Mobility Device users and companies not following safety laws meant to protect all road users, including vulnerable groups. It requests reports from the Municipal Transportation Agency and the companies involved on their compliance with these regulations.

Hearing to address non-compliance by Shared Mobility Device permittees and riders of Shared Mobility Devices with laws and regulations designed to protect the health and safety of riders and pedestrians, including families, seniors and people with disabilities; and requesting the Municipal Transportation Agency and Shared Mobility Device permittees to report.

This hearing focuses on reviewing the Budget and Appropriations Committee's spending plan for 2021-2023, particularly for essential human services. It requests reports from several city departments, including Public Health and Homelessness, on their spending plans.

Hearing on the Budget and Appropriations Committee's 2021-2023 spending plan, specifically departmental spending plans for essential human services; and requesting the Department of Public Health, Department of Homelessness and Supportive Housing, Mayor's Office of Housing and Community Development, and the Office of Economic and Workforce Development to report.

This legislation calls for a hearing to discuss the interim use plan for 730 Stanyan Street. It requests presentations from the Mayor's Office of Housing and Community Development, the Department of Homelessness and Supportive Housing, and the Department of Public Health.

Hearing on the interim use plan for 730 Stanyan Street; and requesting the Mayor's Office of Housing and Community Development, Department of Homelessness and Supportive Housing, and Department of Public Health to present.

This ordinance removes the Life Science and Medical Special Use District from the Planning Code and Zoning Map. It also confirms that the changes align with environmental regulations and the city's General Plan priorities.

Ordinance amending the Planning Code and Zoning Map to eliminate the Life Science and Medical Special Use District; affirming the Planning Department’s determination under the California Environmental Quality Act; making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1; and adopting findings of public necessity, convenience, and welfare under Planning Code, Section 302.

This ordinance extends the restrictions on residential evictions in San Francisco, allowing them only for non-payment of rent, violence, or health and safety issues until December 31, 2021. It amends the Administrative Code to reflect this change.

Ordinance amending the Administrative Code to extend the COVID-19 based limit on residential evictions, which allows evictions only if based on the non-payment of rent or violence or health and safety issues, from September 30, 2021, through December 31, 2021.

The legislation involves a public hearing to discuss proposed ordinances related to a partial settlement of lawsuits against major opioid distributors and manufacturers, seeking abatement funds totaling between $33 million and $61 million over several years. This hearing is scheduled for November 2, 2021, at 3:00 p.m.

Hearing of the Board of Supervisors sitting as a Committee of the Whole on November 2, 2021, at 3:00 p.m., to hold a public hearing to consider the proposed Ordinances (File Nos. 211071 and 211072) regarding existing litigation relating to the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; and the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over nine years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No. 211114), approved on October 26, 2021.

This legislation allows the San Francisco Board of Supervisors to hold a closed session to discuss legal advice regarding ongoing lawsuits against major opioid distributors and manufacturers, seeking settlement funds for the city. The lawsuits aim to secure between $27 million to $50 million and $6 million to $11 million in abatement funds to address the opioid crisis over specified timeframes.

Closed Session for the Board of Supervisors to convene on November 2, 2021, pursuant to California Government Code, Section 54956.9, and San Francisco Administrative Code, Section 67.10(d)(1), for the purpose of conferring with, or receiving advice from the City Attorney regarding existing litigation relating to the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File No. 211071); and the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over nine years, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File No. 211072); scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No. 211114), approved on October 26, 2021.

This ordinance extends various deadlines related to Medical Cannabis Dispensaries and Cannabis Retail Use in San Francisco, pushing them from 2021 to 2022 and 2023. It also allows for the extension of Temporary Cannabis Business Permits and the Cannabis Event Permit pilot program.

Ordinance amending the Health Code, Planning Code, and Police Code to extend the sunset date for provisions governing Medical Cannabis Dispensaries from December 31, 2021, to December 31, 2022; to extend the sunset date for allowing the conversion of Medical Cannabis Dispensaries with Planning Commission approval to a Cannabis Retail Use from January 1, 2022, to January 1, 2023; to allow the extension of Temporary Cannabis Business Permits for additional 120-day terms through December 31, 2022, rather than December 31, 2021; and to allow the extension of the Cannabis Event Permit pilot program through December 31, 2023, rather than December 31, 2021; affirming the Planning Department’s determination under the California Environmental Quality Act; and making findings of consistency with the General Plan, and the eight priority policies of Planning Code, Section 101.1.

This resolution extends the grant agreement with the San Francisco-Marin Food Bank for the COVID-19 Food Assistance Program by six months and increases the total funding by approximately $7.4 million. The new grant term will run from July 1, 2020, to June 30, 2022, starting on October 15, 2021.

Resolution approving a second amendment to the grant agreement between the City and County of San Francisco and San Francisco-Marin Food Bank, for the administration of the COVID-19 Food Assistance Program, to extend the grant term by six months for a total term of July 1, 2020, through June 30, 2022, and to increase the grant amount by $7,424,820 for a total not to exceed amount of $22,951,645 to commence on October 15, 2021.

This resolution allows the Department of Public Health to accept and use a donation of software licenses for an ophthalmology application valued at nearly $60,000, which will support eye care services until June 2025. The donation comes from the San Francisco General Hospital Foundation.

Resolution retroactively authorizing the Department of Public Health to accept and expend an in-kind gift of perpetual software licenses of the ZEISS forum ophthalmology application valued in the amount of $59,949 from the San Francisco General Hospital Foundation for the Department of Public Health to provide eye care and eye disease management for the project period of July 8, 2016, through June 16, 2025.

This resolution supports Mayor London N. Breed in declaring a local emergency due to the overdose crisis and calls for the immediate establishment of overdose prevention sites. It aims to address the rising number of overdose incidents in the city.

Resolution urging and supporting Mayor London N. Breed in proclaiming a declaration of the existence of a local emergency around the overdose crisis and immediately implementing overdose prevention sites.

This resolution officially designates October 2021 as "Children’s Environmental Health Month" in San Francisco to raise awareness about environmental issues affecting children's health. It aims to promote initiatives and education focused on improving the environmental conditions for children in the city.

Resolution recognizing October 2021 as “Children’s Environmental Health Month” in the City and County of San Francisco.

The motion endorses a settlement of a lawsuit against major distributors of prescription opioids, which the City and County of San Francisco filed. It also schedules a public hearing and a closed session for the Board of Supervisors to discuss the litigation with the City Attorney.

Motion calling from the Government Audit and Oversight Committee, pursuant to Board Rule 3.37, the proposed Ordinance (File No. 211071) endorsing settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against large distributors of prescription opioids, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; scheduling the Board of Supervisors to sit as a Committee of the Whole at the meeting on November 2, 2021, at 3:00 p.m. to hold a public hearing to consider the proposed Ordinance; and scheduling a closed session of the Board of Supervisors at the same meeting for the purpose of conferring with, or receiving advice from, the City Attorney regarding that existing litigation in which the City is a plaintiff, pursuant to California Government Code, Section 54956.9(a), and San Francisco Administrative Code, Section 67.10(d)(1).

The motion endorses a settlement in a lawsuit against major distributors of prescription opioids, aimed at addressing the opioid crisis in San Francisco. It also schedules a public hearing and a closed session for the Board of Supervisors to discuss the litigation with the City Attorney.

Motion calling from the Government Audit and Oversight Committee, pursuant to Board Rule 3.37, the proposed Ordinance (File No. 211072) endorsing settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against large distributors of prescription opioids, entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; scheduling the Board of Supervisors to sit as a Committee of the Whole at the meeting on November 2, 2021, at 3:00 p.m. to hold a public hearing to consider the proposed Ordinance; and scheduling a closed session of the Board of Supervisors at the same meeting for the purpose of conferring with, or receiving advice from, the City Attorney regarding that existing litigation in which the City is a plaintiff, pursuant to California Government Code, Section 54956.9(a), and San Francisco Administrative Code, Section 67.10(d)(1).

This motion requires City contractors and subcontractors working closely with City employees to be fully vaccinated against COVID-19 or obtain an exemption by December 31, 2021. It also mandates that members of City boards and commissions report their vaccination status by December 15, 2021, and prohibits unvaccinated members from attending in-person meetings after January 1, 2022.

Motion concurring in actions taken by the Mayor in the Thirty-Eighth Supplement to the Proclamation of Emergency to meet the ongoing local emergency related to the novel coronavirus COVID-19 pandemic by: 1) requiring employees of existing City contractors and subcontractors who spend substantial time working in close proximity to City employees while performing work under the contract at a City facility to be fully vaccinated or granted an exemption based on medical or religious grounds by no later than December 31, 2021; and 2) requiring members of City boards, commissions, and advisory bodies to report vaccination status to the City by no later than December 15, 2021, and prohibiting unvaccinated members from attending in-person meetings of a policy body after January 1, 2022, without exception.

This resolution approves an increase of $3,689,230 to the existing agreement with the Bayview Hunters Point Foundation for Community Improvement, raising the total to $13,489,343, and extends the contract term by fifteen months. It also allows the Department of Public Health to make minor amendments to the contract as needed without significantly increasing the city's obligations.

Resolution approving Amendment No. 2 to the agreement between Bayview Hunters Point Foundation for Community Improvement and the Department of Public Health (DPH) for behavioral health services, to increase the agreement by $3,689,230 for an amount not to exceed $13,489,343; and to extend the term by fifteen months from March 31, 2022, to June 30, 2023, for a total agreement term of July 1, 2018, through June 30, 2023; and to authorize DPH to enter into amendments or modifications to the contract prior to its final execution by all parties that do not materially increase the obligations or liabilities to the City and are necessary to effectuate the purposes of the contract.

This legislation calls for a hearing to review how the city collected and analyzed data on sexual orientation and gender identity for the fiscal years 2019-2021, including any COVID-related data. It requests reports from various city departments, including Public Health and Housing, on their findings.

Hearing on the City's collection and analysis of Sexual Orientation and Gender Identity (SOGI) data for Fiscal Years (FYs) 2019-2020, 2020-2021, and any COVID-related SOGI data, as available; and requesting the Department of Public Health, Mayor's Office of Housing and Community Development, Human Services Agency, Department of Aging and Adult Services, Department of Children, Youth and their Families, and Department of Homelessness and Supportive Housing to report.

This hearing will examine the availability and effectiveness of behavioral health services offered by Kaiser Permanente in the San Francisco Bay Area, focusing on patient wait times and access to care. The Health Service System is requested to provide a report on these issues.

Hearing regarding the availability of behavioral health services provided by Kaiser Permanente in the San Francisco Bay Area and California, including, but not limited to, patient wait times for initial appointments, length of wait time between visits, efficacy of telehealth medicine, and access to follow up care; and requesting the Health Service System to report.

This resolution allows the Department of Public Health to apply for over $5 million in federal funding to support HIV surveillance and prevention programs in San Francisco for the year 2022. It aims to continue efforts in managing and preventing HIV within the community.

Resolution authorizing the Department of Public Health to submit a one-year application for Calendar Year 2022 to continue to receive funding for the Integrated HIV Surveillance and Prevention Programs for Health Departments from the Centers of Disease Control and Prevention, requesting $5,008,377 in HIV prevention funding for San Francisco from January 1, 2022, through December 31, 2022.

The ordinance authorizes a partial settlement of a lawsuit against three major opioid distributors, aiming to secure between $27 million and $50 million in abatement funds over 18 years. This lawsuit alleges that these companies contributed to the opioid crisis in San Francisco by distributing excessive amounts of opioids while ignoring legal obligations to monitor and report suspicious orders.

Ordinance authorizing the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against three large distributors of prescription opioids (AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement funds in the range of $27 million to $50 million to be paid over 18 years; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation created a public nuisance and violated the Unfair Competition Law and the False Advertising Laws by distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and report suspicious opioid orders as required by state and federal law.

The ordinance authorizes a partial settlement of a lawsuit against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, for $6 million to $11 million over nine years due to their role in the opioid crisis. The lawsuit alleges that they created a public nuisance and violated laws through deceptive marketing and distribution of opioids in San Francisco.

Ordinance authorizing the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and the People of the State of California against Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over 9 years; the lawsuit was filed on December 18, 2018, in the United States District Court for the Northern District of California, Case No. 3:18-cv-7591-CRB-JSC; entitled The City and County of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation; the lawsuit involves allegations that Johnson and Johnson’s subsidiary, Janssen Pharmaceuticals, Inc., created a public nuisance and violated the Unfair Competition Law and the False Advertising Laws through deceptive marketing of opioids, manufacturing and distributing increasingly large volumes of opioids in and around San Francisco despite knowledge of the growing epidemic caused by opioid misuse, and by failing to prevent and to report suspicious opioid orders as required by state and federal law.

This ordinance allows the Office of Cannabis to use a $1,000,000 grant for public health and safety initiatives related to Proposition 64, covering the period from May 2021 to October 2024. It also adds a new Senior Administrative Analyst position funded by the grant for one year, from July 2021 to June 2022.

Ordinance retroactively authorizing the Office of Cannabis to accept and expend a grant award in the amount of $1,000,000 from the Board of State and Community Correction for the Proposition 64 Public Health and Safety Grant Program for a term of May 1, 2021, through October 31, 2024; and amending Ordinance No. 166-20 (Annual Salary Ordinance File No. 200568 for Fiscal Years (FYs) 2020-2021 and 2021-2022) to provide for the addition of one grant funded Class 1823 Senior Administrative Analyst position (FTE 1.0) at the Office of Cannabis for the period of July 1, 2021, through June 30, 2022.

This resolution allows the Department of Public Health to use a $405,000 grant from the Hellman Foundation to create clinic-based food "pharmacies" that provide food as a form of medicine. The program will run from May 1, 2022, to May 1, 2025, aiming to connect healthcare systems with the food community.

Resolution authorizing the Department of Public Health to accept and expend a grant in the amount of $405,000 from the Hellman Foundation for participation in a program, entitled “Hellman Foundation Grant,” to help bridge the divide between healthcare systems and the food community through the innovation of providing “food as medicine” through clinic-based food “pharmacies” for the period of May 1, 2022, through May 1, 2025.

This resolution designates specific city departments as Health Care Components under HIPAA, ensuring they comply with health information privacy regulations. It also accepts a report from the City Administrator related to this designation.

Resolution accepting the report of the City Administrator and designating the Department of Public Health, Fire Department, Health Service System, City Attorney, Treasurer-Tax Collector and Department of Technology as Health Care Components under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), pursuant to Administrative Code, Chapter 22H.

This resolution supports the Green New Deal for Public Schools Act of 2021, which aims to invest $1.43 trillion in upgrading public schools to improve health, safety, and accessibility while addressing educational and economic disparities. It also includes funding for special education services.

Resolution supporting the Green New Deal for Public Schools Act of 2021 (H.R. 4442), to invest $1.43 trillion to provide green renovations and retrofits to public schools to meet health, accessibility, safety needs, identify and alleviate educational and economic disparities among students, and provide funding for special education services.

This resolution urges the Department of Public Health to establish consistent standards for healthcare facilities to comply with California's vaccination mandate for staff. It also calls for healthcare providers to support their workers by offering on-site vaccinations and additional paid time off.

Resolution urging the Department of Public Health to set uniform standards for healthcare facilities to fulfill the California Department of Public Health order mandating vaccinations for health care staff, and for healthcare providers to provide support for their workers including on-site vaccinations and supplemental paid time off.

This resolution recognizes abortion as a form of healthcare and opposes Texas Senate Bill 8, while urging support for women's reproductive rights at the federal level. It also declares San Francisco as a Champion of Reproductive Freedom and Justice.

Resolution recognizing Abortion as Healthcare, objecting to Texas Senate Bill 8 and urging approaches that uplift autonomy for women and other birthing people; urging the Biden Administration and Congress to pass legislation protecting Reproductive Rights; and declaring the City and County of San Francisco a Champion of Reproductive Freedom and Justice.

This resolution urges Congress to pass a bill that would establish a Carbon Dividend Trust Fund to promote clean energy innovation and reduce pollution. The goal is to create a healthier and more prosperous future for the nation.

Resolution urging Congress to pass H.R. 2307, authored by Representative Theodore E. Deutch, The Energy Innovation and Carbon Dividend Act of 2021, creating a Carbon Dividend Trust Fund for the American people in order to encourage market-driven innovation of clean energy technologies and market efficiencies which will reduce harmful pollution and leave a healthier, more stable, and more prosperous Nation for future generations.

This resolution urges California Governor Gavin Newsom to extend eviction protections related to COVID-19 until December 31, 2021, or beyond. It aims to provide continued housing security for residents affected by the pandemic.

Resolution urging California Governor Gavin Newsom to extend COVID-related eviction protections to December 31, 2021, or later.

This ordinance temporarily extends the restrictions on residential evictions related to COVID-19, allowing evictions only for non-payment of rent, violence, or health and safety issues. The current limits, set to expire on September 30, 2021, will remain in place for a longer period.

Emergency ordinance to temporarily extend the COVID-19 based limit on residential evictions, which allows evictions only if based on the non-payment of rent or violence or health and safety issues, and which is currently set to expire on September 30, 2021.

This resolution praises Governor Gavin Newsom for signing the Garment Worker Protection Act, which aims to ensure garment workers receive minimum wage and safeguards their health and safety. It highlights the importance of addressing challenges faced by these workers in the industry.

Resolution commending Governor Gavin Newsom for signing Senate Bill No. 62, authored by Senator Maria Elena Durazo, the Garment Worker Protection Act, to eliminate obstacles to workers being paid minimum wage and protecting their health and safety.

This resolution urges President Biden to halt the distribution of COVID vaccine boosters to the general public and to advocate for a waiver on intellectual property rights related to vaccines, while also promoting technology transfer to help low-to-middle income countries. The goal is to support global efforts to end the pandemic.

Resolution urging President Joe Biden to pause distribution of COVID vaccine boosters to the general population and to take a leadership role in supporting the Trade-Related Intellectual Property Rights (TRIPS) waiver while promoting technology information transfer as it relates to vaccinations to low-to-middle income countries in order to end this global pandemic.

The ordinance allows the Office of Economic and Workforce Development to set standards for cannabis-related training programs focused on social equity and business development. It also extends the temporary operating period for medical cannabis dispensaries awaiting permit approval from 120 to between 150 and 180 days, with new requirements related to hiring practices and labor agreements.

Ordinance amending the Police Code to clarify that the Office of Economic and Workforce Development (“OEWD”) may establish standards governing the certification of cannabis-related pre-apprenticeship programs that relate to social equity training, license incubation processes, underserved community outreach programs, and business plan development training; and amending the Health Code to extend from 120 days to between 150 and 180 days the period for which the Director of the Office of Cannabis (“OOC”) may grant temporary authorization to medical cannabis dispensaries (“MCDs”) to continue operating while they wait for the OOC to process their applications for cannabis business permits (“Temporary MCD Authorization”), and to add as prerequisites to Temporary MCD Authorization: that the MCD has not been found to have violated health and safety standards developed by the Director to protect the health and safety of employees, neighbors, and customers; that OEWD has not made a determination, or has determined that the MCD ensures that 35% of its new hires shall be registered apprentices enrolled in an approved apprenticeship program if feasible; and for any MCD with ten or more employees, that OEWD has not made a determination, or has determined that the MCD has entered into or made good faith efforts to enter into a Labor Peace Agreement or a collective bargaining agreement with a Bona Fide Labor Organization.

This legislation initiates a hearing to review the final report from the San Francisco Methamphetamine Task Force, which was completed in 2019. It also requests updates from the Department of Public Health and the Police Department regarding their actions and findings related to the report.

Hearing to follow up on the Final Report of the San Francisco Methamphetamine Task Force from 2019; and requesting the Department of Public Health and the Police Department to report.

This legislation calls for a hearing to discuss the details of Street Teams that assist individuals experiencing homelessness in San Francisco, including their operations and contact methods. It also requests reports from various city departments involved in this effort.

Hearing to determine the scope, hours of operations, launch date, capacity and method to contact the various Street Teams working with individuals experiencing homelessness or in crisis on the Streets of San Francisco; and requesting the Department of Homeless and Supportive Housing, Department of Public Health, Fire Department, Healthy Streets Operations Center, Coalition on Homelessness, and the Department of Emergency Management to report.

This legislation initiates a hearing to evaluate San Francisco's efforts to combat childhood obesity in children under 18, including funding and programs related to this issue. It also requests a report from relevant city departments on data regarding childhood obesity from 2015 to 2020.

Hearing to review the City and County of San Francisco's response to actively address and minimize childhood obesity among children under the age of 18 and to examine what type of funding and programming are aimed at this issue; including to examine data related to the prevalence of childhood obesity spanning the prior five years (2015-2020); and requesting the Department of Children Youth and Their Families, San Francisco Unified School District, and Department of Public Health to report.

The ordinance authorizes a $3,250,000 settlement for a lawsuit regarding alleged medical negligence against the City and County of San Francisco. It also includes a waiver of future wrongful death claims by certain individuals involved in the case.

Ordinance authorizing settlement of the lawsuit filed by David Joslyn against the City and County of San Francisco for $3,250,000; the lawsuit was filed on October 2, 2019, in San Francisco Superior Court, Case No. CGC-19-579230; entitled David Joslyn, et al. v. City and County of San Francisco, et al.; the lawsuit involves alleged personal injury from medical negligence; other material terms of the settlement are that Iris Solano, Frederick Stewart Joslyn and Iris Lorraine Solano waive any potential future claims for wrongful death.

This resolution approves a settlement where Medtronic will pay the City $800,000 and return a fleet of ventilators at their expense. The claim was related to an issue that did not go to court.

Resolution approving the settlement of the unlitigated claim filed by the City against Covidien Sales LLC, a Medtronic Company (Medtronic) for $800,000 including the return of a ventilator fleet at Medtronic’s expense.

This motion allows the City to bypass certain hiring rules to maintain services during the COVID-19 pandemic, extends COVID-19 sick leave for City employees until October 31, 2021, and permits employees to carry over vacation hours beyond the usual limit until June 30, 2022. It aims to address staffing challenges and support employee health and well-being amid ongoing pandemic-related changes.

Motion concurring in actions taken by the Mayor in the Thirty-Seventh Supplement to the Proclamation of Emergency to meet the ongoing local emergency related to the novel coronavirus COVID-19 pandemic by 1) authorizing the waiver of civil service rules to hire employees to ensure the continuity of City services due to the reassignment, suspension, termination, resignation, retirement, or leaves of City employees that may result from vaccination policies or requirements, or return to in-person work requirements; 2) extending the existing COVID-19 sick leave program for City employees to October 31, 2021, and authorizing a possible further extension to December 31, 2021; and 3) allowing City employees to continue to carry vacation hours over the applicable cap until June 30, 2022.

This resolution urges the Municipal Transportation Agency to restore all transit lines and return to pre-Covid service hours by December 31, 2021. It also requests a written plan for this restoration to be released by September 30, 2021.

Resolution urging the Municipal Transportation Agency to reinstate all transit lines and restore pre-Covid service hours by December 31, 2021, and release by September 30, 2021, a written plan for restoration of all lines and service.